designed and screened four chlorotoxin (CLTX)-CAR (T-specific CD3ζ or neutrophil-specific CD32a) constructs to compare their anti-tumor activity with neutrophil-specific signaling domains for targeting glioblastoma multiforme (GBM). The gene discussed is FCGR2A; the disease is glioblastoma.